Abstract
ObjectivesThe chemotherapy response score (CRS) has been developed for measuring response to neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma. This study aimed to validate the ability of this three-tier scoring...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have